Science Corporation, a medical technology startup founded by Max Hodak, has secured $400 million in Series D funding, valuing the company at $3.5 billion. The funding round was led by Khosla Ventures and included other notable investors. The company's initial product, PRIMA, is a chip designed to restore vision for individuals with age-related macular degeneration and is currently undergoing trials for other conditions. Science Corporation also aims to develop a bio-hybrid sensor for direct brain interaction, with potential applications for Parkinson's disease and other neurological conditions. AI
IMPACT This funding could accelerate the development of brain-computer interfaces and neuro-technologies, potentially impacting future AI applications in healthcare and human augmentation.
RANK_REASON Significant funding round for an AI-adjacent medical technology company. [lever_c_demoted from significant: ic=1 ai=0.7]
- 885 Capital
- Ackman Oxman Institute
- Khosla Ventures
- Max Hodak
- Murat Günel
- Neuralink
- Parkinson's disease
- PLC Neurotech
- Science Corporation
- Tenet Healthcare
- United States Food and Drug Administration
- Yale University
- Y Combinator
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →